Australian Dairy Nutritionals Group Overview
Australian Dairy Nutritionals is a vertically integrated, sub-scale producer of organic and organic A2-protein dairy nutritional powders, based in Camperdown in south-west Victoria's dairy "Golden Triangle". It owns one certified-organic A2 dairy farm (Yaringa, Nirranda South) and a small-run infant-formula base-powder plant at Depot Road, Camperdown. After a decade of pivots — from farm aggregator, to fresh-milk processor, to domestic infant-formula brand owner — the group now concentrates almost all its resources on one bet: building its Future™ infant-formula brand in China's mother-and-baby-store channel through an app-based online-to-offline platform. Contract packing for third parties and exports to Vietnam fill the rest of the plant. In FY26 nutritional powders were about 70% of customer revenue. Losses roughly halved to A$2.79M. However, cash was only A$1.16M at year-end, there is a A$1.5M secured loan due in about May 2027, and the auditor flagged a material uncertainty over going concern. Funding risk dominates the investment case.
Company's own description (FY26 Annual Report)
In its FY26 Annual Report, the company describes itself as a vertically integrated Australian dairy group. It says it owns high-quality organic and organic A2-protein dairy farms and a processing facility in south-west Victoria, and that it makes organic A2-protein infant formula from farm-fresh milk from its own farms. The FY26 Directors' Report lists four principal activities:
-
Manufacturing nutritional base powders at 160 Depot Road, Camperdown.
-
Distributing the group's nutritional-powder ranges through Organic Nutritionals Pty Ltd.
-
Owning a dairy farm through Regen Properties Pty Ltd.
-
Operating a dairy farm and owning livestock through SW Dairy Farms Pty Ltd.
Management says the strategy uses three assets: vertical integration, small-run manufacturing, and brand-building capability.
Independent characterisation
In substance, AHF is now an early-stage infant-formula brand owner and contract manufacturer with a farm attached. Its economics are determined by four things:
Volume through a fixed-cost plant: Utilisation drives the absorption of manufacturing overhead. The FY26 accounts explicitly credit higher manufactured volume for the improved segment result.
- Consumer offtake of the Future™ brand in China, sold through distributor Mutree Science and Technology Limited via the AZ Global M2C ("mother-to-consumer") app into mother-and-baby stores.
Episodic contract-packing contracts: (Nutura from November 2024; Sprout from June 2025 to May 2026).
- Market-access events, such as Vietnam's registration change, which halted exports from September 2025.
The farm is now a supporting asset. It supplies organic A2 milk for the plant, sells excess organic milk under contract, and acts as the collateral for the group's only secured borrowing.
Business and revenue model
| Revenue stream | Model | FY26 revenue (AUD Mn) | Share of customer revenue FY26 | Notes |
|---|---|---|---|---|
| Nutritional powders — own brand (Future™, China) | Product sales to an exclusive distributor (Mutree) | Included in 4.940 | Included in 69.9% | Split between own brand and contract pack not disclosed |
| Nutritional powders — contract packing (Nutura, Sprout) | Contract manufacturing (fee/product sale) | Included in 4.940 | Included in 69.9% | Sprout ended May 2026 |
| Nutritional powders — Vietnam export | Product sales to a distributor (Dunamex per FY24 Annual Report) | Included in 4.940 | Included in 69.9% | Suspended September 2025; resumption expected Q1 FY27 |
| Dairy farms — raw organic milk | Commodity sale under a farmgate contract | Included in 2.127 | Included in 30.1% | Contracted to 1 July 2027 at the FY26 price |
| Dairy farms — livestock sales | Spot sales | Included in 2.127 | Included in 30.1% | Volume fell after herd reduction |
| Other (interest, rebates, recoveries) | — | 0.087 | — | Source: FY26 Annual Report, Note 3 |
The mix is 100% product revenue recognised at a point in time. There is no subscription, licensing or service revenue. A former Future-formula subscription model in Australia (FY22) was discontinued along with the Gradulac Gentle range in FY24.
Value-chain position, customers and end-markets
AHF spans the chain from pasture to base powder and branded product. It is not integrated into retail. Its customers are concentrated: two customers accounted for 89% of trade receivables at 30 June 2026 (five customers and 91% at 30 June 2025).
End-markets:
-
China infant milk formula (IMF), mother-and-baby-store/O2O channel
-
Vietnam IMF (distributor model)
-
Australian B2B contract manufacturing
-
Victorian organic farmgate milk
-
Cattle markets
Strategy
Stated strategy (FY26 Annual Report themes)
The FY26 report says the group is executing the strategic plan first set out in the FY24 Annual Report. The main themes, paraphrased:
-
Grow nutritional powders aggressively, with resources focused on building the Future™ brand in China.
-
Use contract packing (Nutura; formerly Sprout), Vietnam and Australia as extra volume for the plant.
-
Use the group's vertical integration, small-run manufacturing and brand-building assets.
-
For FY27 and beyond: sell and distribute the nutritional-powder ranges; make manufacturing more efficient; refine farming operations; manage non-operational costs.
Investor-day materials do not exist publicly.
Strategic initiatives (last 24 months)
| Initiative | Date | Status / targets |
|---|---|---|
| Future™ brand China launch via the AZ Global M2C app | Shipments from March 2025 | Target of 1,000 outlets by FY26 achieved; 17 provinces; Mutree adding sales staff and expanding a sales-incentive plan in FY27 |
| Exclusive Mutree supply agreement (5+5 years) | September 2024 | First-year minimum of 100,000 units / A$2.5M |
| Contract-packing programme | November 2024 to present | Nutura ongoing; Sprout ended May 2026; talks with other parties are continuing |
| Vietnam re-entry | Suspended September 2025 | Resumption guided for Q1 FY27 under the new registration process |
| Brand awareness: CBME Shanghai (July 2026), Vietbaby expo (March 2026) | 2,026 | Aimed at signing new distributors and store owners |
| Farm portfolio reduction (Brucknell North lease exit) | May 2025 | Completed; herd reduced to 657 |
| Ocean Dairy joint-venture termination | 1 June 2026 | AHF now owns 100%; simplifies the Ocean Road Dairies brand position |
| Board renewal (Espie) and China leadership (Zhang as GM China) | July 2026 | Adds operational and supply-chain expertise to the board |
| Cost control | FY25–FY26 | Corporate costs -13% in FY25, +2.5% in FY26 (CPI-level) |
| Capital projects (possible) | Ongoing | Additional dryer or high-speed canning line mentioned as possible projects; no committed spend |
ESG commitments. No formal emissions or sustainability targets have been announced.
Management guidance and medium-term targets
-
Profitability to keep improving in FY27.
-
Positive net profit and cash flow not expected until FY28 (FY26 Annual Report).
-
Cash flows expected to improve over the medium term through wider distribution (Q4 FY26 4C).
-
No numerical revenue, margin or EBITDA targets have been published.
Products & Services
Nutritional Powders segment
| Counterparty | Start | End | Scope | Disclosed value |
|---|---|---|---|---|
| Nutura | First shipment November 2024 | Ongoing | Contract packing of nutritional powders | — |
| Sprout | First shipment June 2025 | Concluded May 2026 (12-month contract) | Contract packing | — |
Future™ infant formula (China).
Description: The group's strategic brand, relaunched as a "differentiated premium" infant formula for China. First shipped in March 2025.
Specifications: Full formulation and stage specifications not publicly disclosed. Company materials position it within the organic and A2-protein proposition and the English-label segment.
Target customer and channel: Chinese parents buying through mother-and-baby stores, reached via the AZ Global M2C app (O2O model), with Mutree as exclusive distributor.
Distribution scale: Five provinces at FY25 year-end; more than 1,000 distribution points across 17 provinces by FY26 year-end.
Momentum: M2C sell-out units grew quarter-on-quarter by 136%, 70%, 80% and 39% across FY26, an average of about 81%.
Pricing: Not disclosed.
Commercial terms: The Mutree agreement requires at least 100,000 units in the first 12 months, worth at least A$2.5M.
- Source: FY25 and FY26 Annual Reports.
Future Gradulac Gentle (discontinued).
Description: A three-step formula with increasing lactose levels, positioned as gentle on babies' digestion.
History: Made by an external contractor. Ranged in Chemist Warehouse from April 2022, also sold on a subscription basis, and through cross-border e-commerce in China via a distributor called GMH. An application was made for accelerated US FDA approval in 2022 (outcome not disclosed).
Exit: Discontinued in FY24 because of poor consumer sales. A$0.419M of stock was written down and A$0.245M of intangibles were impaired.
- Source: FY22 and FY24 Annual Reports.
Ocean Road Dairies Organic A2 infant formula.
Description: A three-stage organic A2-protein range made at Depot Road using milk from the group's own farms.
History: Sold in Chemist Warehouse from November 2022 through the Ocean Dairy joint venture. Also sold on JD.co.hk as an entry point to China (FY24). Domestic offtake was below expectations.
Write-downs: Legacy 2023-dated stock and ingredients were written down by A$0.193M (FY24) and A$0.753M (FY25).
Status: The joint venture ended on 1 June 2026, giving AHF full ownership of the vehicle. The brand is still cited in company boilerplate, but its active commercial status is not disclosed.
Organic A2 whole milk powder and base powders. Base powders made at Depot Road (organic and A2) feed both the group's own brands and contract customers. Plant capacity and run sizes are not disclosed. The company describes the facility as suited to "small run size" manufacturing.
Contract packing services.
Vietnam export range. Infant formula sold through distributor Dunamex. Launched in Q3 FY24. Second-half FY25 sales were more than five times the first half. Suspended from September 2025, with some stock returned, after Vietnam changed its registration and packaging rules. Management expects resumption in Q1 FY27.
Dairy Farms segment
| Product | Description | FY26 metric |
|---|---|---|
| Organic A2 raw milk | Excess milk from Yaringa sold under contract | 2.3ML produced (3.5ML FY25; 5.8ML FY24) |
| Dairy livestock | Sales of surplus cattle | 394 head sold (1,225 FY25) |
| Herd | Closing herd numbers | 657 (766 FY25; 1,674 FY24) |
| Cows milked | Average | 299 (569 FY25; 939 FY24) |
The FY25 farmgate contract included an 11% price increase for 24 months from 1 July 2025. The FY26 Annual Report says excess organic milk is contracted until 1 July 2027 at the FY26 price.
Discontinued and legacy brands
The group previously made or sold these brands, all exited between FY21 and FY23:
Camperdown Dairy: fresh milk, cream and yoghurt; brand retained.
Jonesy's Dairy Fresh: distribution moved to Sealane Group in May 2021.
The Collective: yoghurt made under contract; ended April 2022.
Ecklin South: brand.
Victorian Farmers Direct: home delivery; sold April 2023.
Financial Narrative
Basis. FY2022–FY2026 audited consolidated statements. FY22 figures include the fresh-dairy processing business and are not comparable with later years. FY23 figures are continuing operations unless stated; the FY23 statutory loss including discontinued operations was A$9.394M. AHF does not report gross profit or EBITDA, so those lines are derived (EBITDA = loss before tax + finance costs + depreciation and amortisation).
Income statement
Notes:
-
FY22 EBITDA of -A$3.02M matches the company's reported operating EBITDA.
-
FY22 net loss includes a A$1.555M gain on the sale of Ecklin South.
-
FY24 EPS was restated to -1.13c in the FY25 report.
-
Income tax expense is nil in every year because of losses.
-
The FY25 Chair/CEO letter calls the A$5.26M result an "EBIT loss". It is actually the net loss; derived EBIT is -A$5.14M.
Margins (derived, % of revenue)
Gross profit. Not reported at group level, because expenses are presented by nature. A proxy for nutritional powders is revenue less cost of goods sold, before manufacturing overheads:
Revenue growth. Revenue CAGR FY22–FY26 was -17.0%, distorted by the exit from fresh dairy. On a continuing basis, FY23–FY26 CAGR was +6.9%. FY26 revenue was flat year-on-year (-0.2%); total revenue and other income rose 4%.
Balance sheet
Notes:
-
FY22 working capital includes A$6.425M of Brucknell North held for sale.
-
FY22 accumulated losses are the company's only, excluding the Trust's A$6.85M (shown in non-controlling interests).
-
The FY26 report gives FY25 NTA per share as 3.1c.
-
There is no goodwill. Intangibles are recipes, formulations and trademarks (cost A$0.630M), reclassified in FY26 from indefinite-life to a 10-year finite life.
Cash flow
FY23 operating cash flow includes -A$1.223M from discontinued operations. The FY24 cancellation and buy-back of 7M LTIP loan securities was not a market buyback.
Ratios (derived)
Not meaningful: net debt/EBITDA and interest coverage (EBITDA and EBIT are negative in all years). The cash conversion cycle cannot be computed because group-level COGS is not reported.
Quarterly trajectory, FY26 (Appendix 4C data)
Q1 nutritional powders and Q3 cash/operating cash flow are derived approximations: Q1 NP is not stated in the summaries viewed (Q1 NP growth was +1,239% year-on-year); Q3 operating cash flow is implied from the full-year total; Q3 closing cash is a rough estimate. Treat these cells as indicative only.
Commentary on trends, inflections and drivers
Revenue. Reported revenue fell by more than half between FY22 and FY23 as the group deliberately shut fresh processing (about A$4M of annual revenue) and sold farms. Since then, revenue has been stuck at A$5.9–7.2M because farm revenue has been falling while nutritional powders grow. FY26 is the inflection year: nutritional powders (A$4.94M) are now larger than farm revenue had been in any year since FY24. Further growth no longer has a shrinking farm segment to offset.
Losses. The net loss halved twice: from A$7.44M in FY24 to A$5.26M in FY25, and to A$2.79M in FY26. The drivers were:
-
smaller inventory write-downs (A$0.75M in FY25 to A$0.14M in FY26);
-
a smaller herd, which cut feed and dairy-shed costs (dairy farm costs fell from A$4.14M in FY24 to A$2.17M in FY26);
-
better absorption of manufacturing overhead;
-
non-cash livestock fair-value gains (A$0.76M in FY26).
Corporate costs rose only 2% in FY26. Management guides that profitability will improve in FY27 but that positive net profit and cash flow are not expected until FY28.
Cash. Lower accounting losses have not translated into lower cash burn. Operating outflows were A$3.79M in FY26, higher than A$3.28M in FY25, because inventory rose by A$1.35M (raw materials and finished goods doubled to A$2.32M) to support Chinese distribution. Over five years the group has funded about A$27M of cumulative negative free cash flow through farm sales (about A$26M of proceeds from FY22 to FY24) and equity (A$8.1M). The farm-sale route is now almost exhausted: only Yaringa (carrying value A$8.2M) and the Depot Road plant (A$4.7M) remain, and Yaringa is pledged to RELI Capital.
Balance sheet. Equity has fallen from A$39.9M to A$21.7M in four years. NTA per share has fallen from 7.2c to 2.7c. FY26 was the first year of net debt (A$0.46M) since the group became debt-free. Unrecognised tax assets of A$14.3M (tax-effected) are a hidden asset, but the company warns that its ability to use the losses is uncertain under the continuity-of-ownership and same-business tests.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Role | Ownership |
|---|---|---|
Australian Dairy Nutritionals Limited | Listed parent, head of the tax-consolidated group | Listed |
Organic Nutritionals Pty Ltd | Distributes the nutritional-powder ranges | 100% |
Regen Properties Pty Ltd | Owns the Yaringa farm land; borrower under the RELI facility | 100% |
SW Dairy Farms Pty Ltd | Operates the farm; owns livestock | 100% |
Ocean Dairy Pty Ltd | Former Ocean Road Dairies joint venture with Wellnex Life | 50% until 1 June 2026, then 100% |
Camperdown Dairy Company Pty Ltd | Former fresh-milk processor; brand retained | Status not confirmed in FY26 materials |
Revenue by Segment
| Segment | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Nutritional Powders revenue & other income (AUD Mn) | 0.413 | 0.668 | 3.072 | 5.096 |
Dairy Farms revenue & other income (AUD Mn) | 5.442 | 5.595 | 4.691 | 2.996 |
Total segment revenue & other income (AUD Mn) | 5.856 | 6.263 | 7.763 | 8.093 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment by Service Line
| Service line | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Nutritional powders (AUD Mn) | 0.407 | 0.641 | 3.072 | 4.940 |
Dairy farms (AUD Mn) | 5.397 | 5.534 | 3.962 | 2.127 |
Results by Segment
| Segment result | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Nutritional Powders net result (AUD Mn) | -3.860 | -3.704 | -3.041 | -1.301 |
Dairy Farms net result (AUD Mn) | -0.724 | -1.929 | -0.652 | 0.113 |
Corporate costs (AUD Mn) | -2.505 | -1.806 | -1.568 | -1.606 |
Segment expenses
| Segment expenses | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Nutritional Powders expenses (AUD Mn) | 4.273 | 4.373 | 6.113 | 6.397 |
Dairy Farms expenses (AUD Mn) | 6.166 | 7.524 | 5.343 | 2.883 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Nutritional Powders YoY revenue growth (%) | 61.7 | 359.9 | 65.9 |
Dairy Farms YoY revenue growth (%) | 2.8 | -16.2 | -36.1 |
Nutritional Powders net margin (%) | -554.6 | -99.0 | -25.5 |
Dairy Farms net margin (%) | -34.5 | -13.9 | 3.8 |
Nutritional Powders share of segment revenue (%) | 10.7 | 39.6 | 63.0 |
Nutritional Powders share of customer revenue (%) | 10.4 | 43.7 | 69.9 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (AUD Mn) | 15.063 | 5.856 | 6.263 | 7.168 | 7.154 |
Other income (AUD Mn) | 2.898 | 0.000 | 0.000 | 0.595 | 0.939 |
Depreciation & amortisation (AUD Mn) | 0.995 | 0.753 | 1.048 | 0.861 | 0.548 |
Finance costs (AUD Mn) | 0.132 | 0.057 | 0.136 | 0.117 | 0.056 |
EBITDA derived (AUD Mn) | -3.021 | -6.279 | -6.255 | -4.283 | -2.190 |
EBIT derived (AUD Mn) | -4.016 | -7.032 | -7.303 | -5.144 | -2.738 |
Loss before tax continuing (AUD Mn) | -4.149 | -7.088 | -7.439 | -5.261 | -2.794 |
Net loss total (AUD Mn) | -4.149 | -9.394 | -7.439 | -5.261 | -2.794 |
Net loss attributable to members (AUD Mn) | -4.148 | -9.329 | -7.356 | -5.209 | -2.842 |
Basic EPS (AUD cents) | -0.81 | -1.68 | -1.14 | -0.72 | -0.37 |
Diluted EPS (AUD cents) | -0.81 | -1.68 | -1.14 | -0.72 | -0.37 |
Dividends per share (AUD cents) | 0 | 0 | 0 | 0 | 0 |
Margin
| Margin | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
EBITDA margin (%) | -20.1 | -107.2 | -99.9 | -59.7 | -30.6 |
EBIT margin (%) | -26.7 | -120.1 | -116.6 | -71.8 | -38.3 |
Net margin continuing (%) | -27.5 | -121.0 | -118.8 | -73.4 | -39.1 |
Income Statement and Margin Analysis (%)
| Nutritional powders proxy | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
NP revenue less COGS (AUD Mn) | 0.180 | 0.767 | 1.259 |
NP COGS gross margin proxy (%) | 28.1 | 25.0 | 25.5 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash & equivalents (AUD Mn) | 2.432 | 2.007 | 6.106 | 2.688 | 1.157 |
Trade & other receivables (AUD Mn) | 0.974 | 0.660 | 0.598 | 1.261 | 1.441 |
Inventories (AUD Mn) | 1.399 | 1.507 | 1.624 | 1.340 | 2.733 |
Biological assets (AUD Mn) | 4.416 | 3.761 | 1.874 | 1.055 | 1.471 |
Property plant & equipment (AUD Mn) | 27.003 | 26.382 | 18.852 | 18.162 | 17.643 |
Goodwill & intangibles (AUD Mn) | 0.547 | 0.636 | 0.394 | 0.383 | 0.383 |
Total assets (AUD Mn) | 44.603 | 36.240 | 30.347 | 25.089 | 25.219 |
Borrowings short-term (AUD Mn) | 0.503 | 0.000 | 1.740 | 0.000 | 1.470 |
Borrowings long-term (AUD Mn) | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
Lease liabilities current (AUD Mn) | 0.243 | 0.556 | 0.464 | 0.048 | 0.055 |
Lease liabilities non-current (AUD Mn) | 0.346 | 0.485 | 0.048 | 0.000 | 0.096 |
Total debt incl leases (AUD Mn) | 1.091 | 1.041 | 2.253 | 0.048 | 1.620 |
Net debt (AUD Mn) | -1.341 | -0.966 | -3.853 | -2.640 | 0.463 |
Total liabilities (AUD Mn) | 4.654 | 2.716 | 3.620 | 1.441 | 3.482 |
Total equity (AUD Mn) | 39.948 | 33.523 | 26.727 | 23.647 | 21.737 |
Working capital (AUD Mn) | 7.853 | 2.476 | 5.400 | 4.163 | 2.300 |
Accumulated losses (AUD Mn) | 35.542 | 49.054 | 53.463 | 58.672 | 61.667 |
NTA per share (AUD cents) | 7.2 | 5.4 | 4.1 | 3.2 | 2.7 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | -3.795 | -7.051 | -4.439 | -3.276 | -3.790 |
Capex PP&E (AUD Mn) | 2.576 | 0.826 | 0.249 | 0.188 | 0.476 |
Capex intangibles (AUD Mn) | 0.142 | 0.110 | 0.032 | 0.000 | 0.000 |
Free cash flow derived (AUD Mn) | -6.513 | -7.987 | -4.720 | -3.464 | -4.266 |
Asset sale proceeds (AUD Mn) | 5.886 | 7.147 | 7.016 | 0.141 | 0.182 |
Net equity raised (AUD Mn) | 2.734 | 1.434 | 0.642 | 2.122 | 1.166 |
Net secured borrowing (AUD Mn) | -5.981 | 0.000 | 1.676 | -1.780 | 1.467 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%) | -11.2 | -25.6 | -24.7 | -20.9 | -12.3 |
ROA (%) | -9.5 | -23.2 | -22.3 | -19.0 | -11.1 |
ROIC pre-tax (%) | -10.4 | -21.6 | -31.9 | -24.5 | -12.3 |
Current ratio (x) | 2.86 | 2.13 | 2.52 | 3.92 | 1.68 |
Debt to equity (x) | 0.03 | 0.03 | 0.08 | 0.00 | 0.07 |
Asset turnover (x) | 0.34 | 0.14 | 0.19 | 0.26 | 0.28 |
Days sales outstanding (days) | 23.6 | 41.2 | 34.9 | 64.2 | 73.5 |
Income Statement
| Metric | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 |
|---|---|---|---|---|
Consolidated revenue (AUD Mn) | 1.9 | 1.4 | 1.4 | 2.6 |
Nutritional powders revenue (AUD Mn) | 1.0 | 0.776 | 0.880 | 2.1 |
Net operating cash flow (AUD Mn) | -0.655 | -1.11 | -0.625 | -1.4 |
Closing cash (AUD Mn) | 1.9 | 0.809 | 0.6 | 1.2 |
Geographies of Trade-receivable Credit Exposure by Year
| Year | Geographies of trade-receivable credit exposure | Interpretation |
|---|---|---|
FY2024 | Australia only | Pre-China launch; Vietnam receivables not material at year-end |
FY2025 | Australia, Vietnam, Hong Kong | Hong Kong likely the invoicing point for China (Mutree); Vietnam active |
FY2026 | Australia, Hong Kong | Vietnam suspended from September 2025 |
Markets
| Market | Segment | FY26 status | Direction |
|---|---|---|---|
China (via Hong Kong / Mutree) | Nutritional Powders | Primary growth engine; 1,000+ outlets in 17 provinces | Fastest-growing |
Australia (contract packing) | Nutritional Powders | Nutura ongoing; Sprout ended May 2026 | Mixed / declining in FY27 |
Vietnam | Nutritional Powders | Suspended September 2025; resumption guided Q1 FY27 | Declined sharply in FY26 |
Australia (Victoria farmgate and cattle) | Dairy Farms | Shrinking after lease exits | Declining |
Share Price History
| Date | Price (AUD) | Context |
|---|---|---|
March 2022 | about 0.065 | IJ Funds placement price |
July 2023 / September 2024 | 0.022 | Placement prices |
March 2025 | up to 0.056 | Chair's on-market purchases |
30 October 2025 | 0.038 | Q1 FY26 4C release |
21–22 January 2026 | 0.027–0.029 | Q2 4C / trading halt |
January–February 2026 | 0.028 | Entitlement offer price |
21 May 2026 | 0.022 | RELI loan announcement |
31 July 2026 | 0.017 | Q4 FY26 4C |
Latest | about 0.016 | Recent quote |
Share Count (M) and Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Weighted average shares (M) | 511.5 | 559.6 | 650.4 | 723.4 | 768.0 |
Net equity raised (AUD Mn) | 2.734 | 1.434 | 0.642 | 2.122 | 1.166 |
Dividends per share (AUD cents) | 0 | 0 | 0 | 0 | 0 |
Valuation Multiples
| Multiple | AHF | Basis |
|---|---|---|
Market capitalisation | about A$12.6M | about 787M shares |
Enterprise value | about A$13.1M | Plus A$1.62M debt and leases, less A$1.16M cash |
EV / Sales (FY26) | about 1.8x | Revenue A$7.15M |
P / Book | about 0.58x | Equity A$21.74M |
Price / NTA | about 0.59x | NTA 2.7c |
Capital Instruments
| Instrument | Amount | Maturity | Terms |
|---|---|---|---|
RELI Capital secured loan (borrower Regen Properties; AHF guarantor) | A$1.5M (carrying value A$1.47M) | about 29 May 2027 | 9.74% variable, prepaid; establishment fee A$24,750; loan-to-value cap 40%; secured on Yaringa plus general security over the borrower's related assets |
Lease liabilities | A$0.150M | A$0.055M current; A$0.096M non-current | Land lease |
Unsecured short-term borrowings | Nil at year-end | Drawn and repaid within FY26 (A$0.327M) | Likely premium funding (nature not specified) |
Analyst Conclusions
Management guidance
-
Profitability to improve further in FY27.
-
Positive net profit and cash flow not expected until FY28.
-
Vietnam shipments to resume in Q1 FY27.
-
Further distribution and provincial expansion in China during FY27.
-
The board is confident it can raise capital as needed.
No numerical guidance has been given. Consensus growth expectations are not publicly disclosed.
Bull case
-
Operating leverage is visible. Nutritional-powder revenue rose 66% in FY26 while segment costs rose 5%, and the segment loss fell to A$1.30M. Another year of strong growth in Chinese offtake could bring the segment to break-even, especially with Vietnam returning.
-
Strong downside asset cover. Farm and plant carrying values of about A$13M, plus total equity of A$21.7M, compare with a market capitalisation of about A$12.6M. The shares trade at about 0.6x NTA, and A$14.9M of unrecognised tax losses add optional value.
-
People and channel fit. A chair with a proven a2 Milk Asia record (who keeps buying shares), a China GM with distribution experience, and an exclusive distributor that is expanding its sales force give the Future™ brand a credible route to scale in a fragmented A$25.5bn market where A2 is gaining share.
Bear case
-
Funding is the main constraint. Cash of A$1.16M against annual operating burn of about A$3.8M, a A$1.5M loan due about May 2027, and an auditor's material uncertainty point to a near-term raising at depressed prices. The 2026 entitlement offer needed a shortfall placement, and further dilution is likely.
-
Volume concentration and fragility. One China distributor, two customers holding 89% of receivables, the Sprout contract ended, and Vietnam suspended. Each FY26 quarter showed volatility: revenue swung between A$1.4M and A$2.6M.
-
Execution history. Two earlier infant-formula brands (Future Gradulac Gentle; Ocean Road Dairies) failed commercially, producing about A$2.3M of inventory write-downs between FY23 and FY25. China's newborn decline and the dominance of large incumbents make sustained share gains hard for a brand with a A$0.37M marketing budget.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| By about 31 October 2026 | Q1 FY27 4C: evidence of Vietnam resumption; nutritional-powder revenue run-rate against Q4's A$2.1M; cash balance |
| About October–November 2026 | AGM: remuneration-report vote (a new strike cycle starts), any capital-raising authority |
| H2 CY2026 | New contract-packing agreement to replace Sprout (company has committed to disclose) |
| Ongoing | China outlet count beyond 1,000; province expansion beyond 17; repeat-purchase metrics |
| February 2027 | H1 FY27 interim: segment break-even progress; going-concern language |
| By May 2027 | RELI loan refinancing or repayment; equity raise size and pricing |
| Ongoing | China SAMR and Vietnam registration developments; Australian seasonal conditions and feed costs |
| Ongoing | Insider trading by the chair and directors (Appendix 3Y) |
Analyst verdict
Australian Dairy Nutritionals has, after a decade of costly reinvention, arrived at a coherent and focused strategy. It is a small-run organic A2 nutritional-powder maker with its own milk supply and a single, measurable growth vector: the Future™ brand in China's mother-and-baby-store channel. FY26 delivered the clearest evidence yet that the model can work. Nutritional powders grew 66% to about 70% of customer revenue, the distribution target of 1,000 outlets was reached on schedule, quarterly sell-out compounded at about 81%, and the group loss fell 47% to A$2.79M with corporate costs held flat in real terms.
The equity story, however, is dominated by the balance sheet, not the income statement. Operating cash outflows actually rose in FY26 to A$3.79M as inventory was built for China. Year-end cash of A$1.16M covers roughly one quarter of burn. The group's only debt — a A$1.5M facility secured on the Yaringa farm — falls due in about May 2027. Management does not expect positive cash flow until FY28. The auditor's material-uncertainty paragraph is therefore a real constraint, not a formality. The most likely path is a further equity raising, or the monetisation of farm assets, before or around mid-2027. Both would dilute or shrink the asset backing that currently supports the share price at about 0.6x NTA.
For investors, AHF is a high-risk, binary micro-cap option on China execution. The bull case requires nutritional-powder revenue to keep growing at least 50% a year, Vietnam to return, a replacement contract-packing customer to be found, and funding on acceptable terms. The bear case needs only one more funding round at a discount. Our stance: speculative; monitor rather than accumulate until the Q1–Q2 FY27 quarterly reports show both continued revenue momentum and a credible funding solution. Asset backing limits, but does not remove, permanent capital-loss risk.
APPENDIX: SOURCES
-
Australian Dairy Nutritionals Group, Appendix 4E and Annual Report FY2026 (27 August 2026): https://investorpa.com/announcement-pdf/20260827/334305.pdf
-
Australian Dairy Nutritionals Group, Appendix 4E and Annual Report FY2025 (29 August 2025): https://announcements.asx.com.au/asxpdf/20250829/pdf/06nk9l7py41ymx.pdf
-
Australian Dairy Nutritionals Group, Appendix 4E and Annual Report FY2024 (30 August 2024): https://announcements.asx.com.au/asxpdf/20240830/pdf/0679yg7tzlsg51.pdf
-
Australian Dairy Nutritionals Group, Appendix 4E and Annual Report FY2022 (31 August 2022): https://www.asx.com.au/asxpdf/20220831/pdf/45dl4r96qxpz2l.pdf
-
Australian Dairy Nutritionals Group, Interim Financial Report H1 FY2026 (26 February 2026): https://announcements.asx.com.au/asxpdf/20260226/pdf/06wtb730d2bp81.pdf
-
Australian Dairy Nutritionals Group, Interim Financial Report H1 FY2023: https://announcements.asx.com.au/asxpdf/20230228/pdf/45m4vxyh0x144w.pdf
-
Australian Dairy Nutritionals Group, Annual Report FY2023: https://announcements.asx.com.au/asxpdf/20230831/pdf/05tckkqr0q2ts7.pdf
-
AHF Appendix 4C, Q2 FY26 (21 January 2026): https://bulletin.webull.com/qbd/announcement/20260121/499501606/a395ab396e6d94a8f3a359f78ed5a8d1.pdf
-
AHF Appendix 4C, Q3 FY26 (30 April 2026): https://bulletin.webull.com/qbd/announcement/20260430/499501606/43b719fdf9661fc74ea7df5c46999fd5.pdf
-
AHF Placement of Entitlement Offer Shortfall (15 May 2026): https://bulletin.webull.com/qbd/announcement/20260515/499501606/0a06f20e369c4f3252e8ae801c632bee.pdf
-
InvestSMART announcement summaries (Q1 FY26 4C; Q2 FY26 4C; trading halt; H1 FY26; RELI loan; Q4 FY26 4C) and share price: https://www.investsmart.com.au/security/asx/ahf/australian-dairy-nutritionals-group
-
Simply Wall St ownership and insider transactions (S&P Global data): https://simplywall.st/stocks/au/food-beverage-tobacco/chia-ahf/australian-dairy-nutritionals-shares/ownership
-
StockAnalysis, Frankfurt F9H quote: https://stockanalysis.com/quote/fra/F9H/
-
TipRanks, AHF income statement (weighted shares): https://www.tipranks.com/stocks/au:ahf/financials/income-statement
-
Bubs Australia, Appendix 4E FY2025: https://announcements.asx.com.au/asxpdf/20250829/pdf/06nkpggrwwfgkr.pdf
-
Just Drinks, Noumi H1 FY25 results (25 February 2025): https://www.just-drinks.com/newsletters/australias-noumi-reveals-loss-linked-to-a50m-impairment-charge
-
Australian Manufacturing, AHF to acquire Camperdown Dairy Company: https://www.australianmanufacturing.com.au/?p=34890
-
The Standard, Camperdown Dairy sale (A$11M): https://www.standard.net.au/story/3622540/revived-dairy-changes-owners/
-
FNN, AHF update on CDC acquisition (16 March 2016): https://finnewsnetwork.com.au/archives/finance_news_network122775.html
-
Business News, Australian Dairy Farms Group profile: https://businessnews.com.au/Company/Australian-Dairy-Farms-Group
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Background | Education | Shareholding |
|---|---|---|---|---|---|
Peter Nathan | Executive Chairman | 3 June 2024 (non-executive chair initially) | Former Asia Pacific CEO of the a2 Milk Company over a 14-year tenure, during which a2 revenue grew from A$7M to A$1.3bn per company bio; earlier sales and marketing roles at Colgate-Palmolive and Gillette; non-executive director of Comvita (NZX) since 20 July 2026 | Bachelor of Business (Marketing), University of South Australia | 15,073,518 shares; 3,000,000 options |
Jason (Zhao Hui) Dong | Non-Executive Director | 15 April 2021 | Australia–China trade adviser; former adviser and research fellow at the Chinese Academy of Agricultural Sciences; former Alinta Energy board member; director of City Cable Australia | Master of Commerce (Melbourne); Bachelor of Economics (Shanxi University of Finance & Economics) | 500,000 shares |
Scott (Qing) Lai | Non-Executive Director | 7 August 2023 | Founder of IJ Financial Services (2017); director of IJ Funds Management, a major shareholder since 2022 | Bachelor and Master of Commerce (Griffith) | 49,064,135 shares |
Daniel Espie | Independent Non-Executive Director | 6 July 2026 | 28+ years in food, dairy (including infant formula), logistics and supply chain; senior roles at Fonterra, NewCold and IXOM | Bachelor of Technology and Postgraduate Diploma in Business (Massey) | Nil |
Andy Zhang (former) | Non-Executive Director | 2 October 2024 to 6 July 2026 | Built a cross-border infant-formula distribution business to about A$400M of revenue; nominee of Alpha Professional Holdings; now General Manager – China | Master of Commerce, Professional Accounting (Deakin) | 707,506 shares |
Executive Leadership Team
| Name | Title | Tenure | Notes |
|---|---|---|---|
Sundaranathan Mahinthan | Group CEO | Since 18 June 2024 | Three-month notice period; prior career and education not disclosed in the annual reports reviewed |
Peter Nathan | Executive Chairman | Since 2024 | See above |
Andy Zhang | General Manager – China | Since 6 July 2026 | Moved from the board |
Elizabeth Spooner | Company Secretary (outsourced, Confidant Partners) | Since 22 February 2024 | Juris Doctor (ANU) |
Directors' Remuneration
| KMP | Salary/fees | Annual leave | Super | Share-based payments | Total FY26 | Total FY25 |
|---|---|---|---|---|---|---|
Peter Nathan | 100,125 | 0 | 12,015 | 14,725 | 126,865 | 122,839 |
Sundaranathan Mahinthan | 331,545 | 28,955 | 30,000 | 59,832 | 450,332 | 420,999 |
Scott Lai | 65,000 | 0 | 7,800 | 0 | 72,800 | 72,475 |
Jason Dong | 60,000 | 0 | 7,200 | 0 | 67,200 | 66,900 |
Andy Zhang | 60,000 | 0 | 7,200 | 0 | 67,200 | 49,995 |
Total | 616,670 | 28,955 | 64,215 | 74,557 | 784,397 | 733,208 |
Major Shareholders
| Holder | Shares | Approx. % | Source / basis |
|---|---|---|---|
Scott Lai (relevant interest, linked to IJ Funds Management) | 49,064,135 | about 6.2% of about 787M | FY26 Annual Report |
Miracle Plant Developments Limited | 48,477,509 | 6.52% (of about 743M, January 2026) | S&P Global via Simply Wall St |
Fire Dragon Capital Pty Ltd | Not stated | 6.52% (January 2026) | S&P Global via Simply Wall St |
Peter Nathan | 15,073,518 | about 1.9% | FY26 Annual Report |
Sundaranathan Mahinthan | 2,000,000 | about 0.25% | FY26 Annual Report |
Andy Zhang | 707,506 | about 0.1% | FY26 Annual Report |
Jason Dong | 500,000 | about 0.06% | FY26 Annual Report |
Competitive Landscape
Peer Comparison FY2026
| Metric | AHF (FY26) | Bubs Australia (FY25) | Noumi (H1 FY25) | a2 Milk Co (FY25) |
|---|---|---|---|---|
Revenue | A$7.15M | A$102.5M | A$299.3M (half-year) | — |
Revenue growth | -0.2% (powders +66%) | +29% | +2.6% | — |
Profitability | Net loss A$2.79M | Profit after tax A$5.5M | Net loss A$82.1M (including A$50M impairment); adjusted EBITDA A$27.5M | — |
China revenue | — | A$21.1M (+22%) | Not applicable | Core market |
Net margin | -39.1% | about 5.4% | Negative | Positive |
“—” = not publicly disclosed.
Recent Developments
--



